Ulrika WARPMAN BERGLUND
Company: Oxcia
Job title: CEO
Seminars:
What is Next for DDR Inhibitors Outside Oncology? 3:30 pm
• Rethink what disorders could be treated with DDR inhibitors • Incorporating lessons from oncology and ponder DDR inhibitors for fibrosisRead more
day: Day Two